Park West Asset Management LLC - GALMED PHARMACEUTICALS LTD ownership

GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 9 filers reported holding GALMED PHARMACEUTICALS LTD in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Park West Asset Management LLC ownership history of GALMED PHARMACEUTICALS LTD
ValueSharesWeighting
Q1 2018$2,026,000
-24.4%
363,700
+24.2%
0.09%
-26.2%
Q4 2017$2,679,000
+4.5%
292,847
+4.4%
0.12%
-20.3%
Q3 2017$2,564,000
+101.3%
280,500
+36.5%
0.15%
+115.5%
Q2 2017$1,274,000
+26.8%
205,5000.0%0.07%
+20.3%
Q1 2017$1,005,000
+39.4%
205,5000.0%0.06%
+5.4%
Q4 2016$721,000
-20.9%
205,5000.0%0.06%
-32.5%
Q3 2016$912,000
-1.2%
205,5000.0%0.08%
-10.8%
Q2 2016$923,000
-8.9%
205,5000.0%0.09%
-2.1%
Q1 2016$1,013,000
-35.2%
205,5000.0%0.10%
-43.8%
Q4 2015$1,564,000
+2.4%
205,5000.0%0.17%
+21.6%
Q3 2015$1,527,000
-24.4%
205,500
+2.3%
0.14%
-26.1%
Q2 2015$2,020,000
+6.3%
200,788
-0.5%
0.19%
-32.1%
Q1 2015$1,901,000
+62.3%
201,8480.0%0.28%
+48.9%
Q4 2014$1,171,000
-32.5%
201,8480.0%0.19%
-27.6%
Q3 2014$1,736,000
-11.7%
201,8480.0%0.26%0.0%
Q2 2014$1,966,000
-14.3%
201,848
+0.9%
0.26%
-1.5%
Q1 2014$2,294,000200,0000.26%
Other shareholders
GALMED PHARMACEUTICALS LTD shareholders Q1 2017
NameSharesValueWeighting ↓
Ibex Investors LLC 339,000$4,034,0002.29%
Knoll Capital Management, LLC 210,000$2,499,0002.12%
BVF INC/IL 1,761,567$20,963,0002.05%
Vivo Capital, LLC 792,707$9,433,0001.22%
P.A.W. CAPITAL CORP 95,000$1,131,0001.14%
683 Capital Management, LLC 1,350,000$16,065,0001.09%
Unterberg Capital LLC 50,000$595,0000.70%
SABBY MANAGEMENT, LLC 232,224$2,763,0000.43%
Nantahala Capital Management 741,108$8,819,0000.36%
DAFNA Capital Management LLC 50,000$595,0000.28%
View complete list of GALMED PHARMACEUTICALS LTD shareholders